Skip to main navigation Skip to search Skip to main content

Substrate-Guided Design of Selective FXIIa Inhibitors Based on the Plant-Derived Momordica cochinchinensis Trypsin Inhibitor-II (MCoTI-II) Scaffold

  • Joakim E. Swedberg
  • , Tunjung Mahatmanto
  • , Hafiza Abdul Ghani
  • , Simon J. De Veer
  • , Christina I. Schroeder
  • , Jonathan M. Harris
  • , David J. Craik*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Thrombosis is a leading cause of morbidity and mortality associated with cardiovascular diseases. Inhibition of factor XIIa (FXIIa) provides thrombus protection without bleeding complications. Here, we defined the extended substrate specificity of FXIIa and its close homologue factor Xa and used these data, together with inhibitor-based and structure-guided methods, to engineer selective FXIIa inhibitors based on Momordica cochinchinensis trypsin inhibitor-II.

Original languageEnglish
Pages (from-to)7287-7292
Number of pages6
JournalJournal of Medicinal Chemistry
Volume59
Issue number15
DOIs
Publication statusPublished - 11 Aug 2016
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Substrate-Guided Design of Selective FXIIa Inhibitors Based on the Plant-Derived Momordica cochinchinensis Trypsin Inhibitor-II (MCoTI-II) Scaffold'. Together they form a unique fingerprint.

Cite this